A phase II study of α-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Investigational new drugs

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00179593
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhancement of the antiproliferative activity of human interferon by polyamine depletion.

  1985cited by this paper
• Enhancement of the antiproliferative activity of human interferon by polyamine depletion.

  1985cited by this paper
• Effects of α-Difluoromethylornithine on the Growth of 9L Rat Brain Tumor Multicellular Spheroids and Their Response to 1,3-Bis(2-chloroethyl)-1-nitrosourea

  1984cited by this paper
• Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis.

  1984cited by this paper
• Effects of cloned human leukocyte interferons in the human tumor stem cell assay.

  1983cited by this paper
• Polyamine metabolism and function.

  1982cited by this paper
• New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assay.

  1981cited by this paper
• Synergistic action of two polyamine antimetabolites leads to a rapid therapeutic response in childhood leukemia

  1981cited by this paper
• Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.

  1981cited by this paper
• Inhibition of human melanoma colony formation by retinoids.

  1979cited by this paper
• Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on L1210 leukemia in mice.

  1978cited by this paper
• Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.

  1978cited by this paper
• Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogs

  1978cited by this paper
• Anti-proliferative properties of DL-alpha-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase.

  1978cited by this paper
• DTIC (NSC-45388) in malignant melanoma: a perspective.

  1976cited by this paper

• Polyamine Derived Photosensitizer: A Novel Approach for Photodynamic Therapy of Cancer

  2024cites this paper
• Eflornithine for chemoprevention in the high-risk population of colorectal cancer: a systematic review and meta-analysis with trial sequential analysis

  2023cites this paper
• Quimioprevenção e câncer no contexto brasileiro: Da higidez ao diagnóstico

  2021cites this paper
• Diverse Functions of Polyamines in Virus Infection

  2020cites this paper
• Computational approaches for drug discovery against trypanosomatid-caused diseases

  2020cites this paper
• Antiviral activity of N-ω-Chloroacetyl-L-Ornithine on in vitro replication of Chikungunya virus

  2019cites this paper
• Comparison of Automated Hearing Testing Approaches for Outpatients Receiving Ototoxic Chemotherapy

  2019cites this paper
• Supramolecular trap for catching polyamines in cells as an anti-tumor strategy

  2019cites this paper
• Methionine metabolism in health and cancer: a nexus of diet and precision medicine

  2019cites this paper
• pH gradient-liquid chromatography tandem mass spectrometric assay for determination of underivatized polyamines in cancer cells.

  2018cites this paper
• Ursolic Acid, a Natural Pentacylcic Triterpene from Ochrosia elliptica and Its Role in The Management of Certain Neglected Tropical Diseases

  2016cites this paper
• Targeting polyamine metabolism for cancer therapy and prevention.

  2016cites this paper
• Characterisation of cyto- and genotoxicity of novel bisnaphthalpolyamines within pancreatic cancer cells

  2014cites this paper
• Skin Cancer Prevention

  2014cites this paper
• Polyamines metabolism and breast cancer: state of the art and perspectives

  2014cites this paper
• Phase 1 study of N1,N11-diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma

  2013cites this paper
• Chemoprevention of melanoma.

  2012cites this paper
• Skin Cancer Prevention

  2011cites this paper
• Synergy of Eflornithine Cream with Laser and Light-Based Systems for Hair Management

  2009cites this paper
• Spermine metabolism and anticancer therapy.

  2009cites this paper
• Recent advances in the development of polyamine analogues as antitumor agents.

  2009cites this paper
• Longitudinal Assessment of Air Conduction Audiograms in a Phase III Clinical Trial of Difluoromethylornithine and Sulindac for Prevention of Sporadic Colorectal Adenomas

  2008cites this paper
• Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases

  2007cites this paper
• Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential

  2007cites this paper
• α‐Difluoromethylornithine, a polyamine inhibitor: its potential role in controlling hair growth and in cancer treatment and chemo‐prevention

  2006cites this paper
• The cell clone ecology hypothesis and the cell fusion model of cancer progression and metastasis (II): three pathways for spontaneous cell-cell fusion and escape from the intercellular matrix.

  2006cites this paper
• Unusual central nervous system toxicity in a phase I study of N1N11diethylnorspermine in patients with advanced malignancy

  2004cites this paper
• Irreversible ototoxicity associated with difluoromethylornithine.

  2004cites this paper
• Prevention of metastasis of intraocular melanoma in mice treated with difluoromethylornithine

  2004cites this paper
• Chemoprevention of melanoma: an unexplored strategy.

  2003cites this paper
• Iron as a comorbid factor in chronic viral hepatitis

  2002cites this paper
• A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers.

  2002cites this paper
• Prostate cancer old problems and new approaches

  1996cites this paper
• Prostate cancer old problems and new approaches

  1996cites this paper